Colgate-Palmolive Company has elected Christopher S. Boerner, the CEO and Board Chair of Bristol-Myers Squibb, to its Board of Directors effective March 15, 2026. Additionally, Steven A. Cahillane announced he will not stand for reelection to the Board at the company's Annual Meeting of Stockholders on May 8, 2026.
